Bionovate Technologies Corp
BIIO
$0.0001
$0.000.00%
OTC PK
| 09/30/2021 | 06/30/2021 | 03/31/2021 | 12/31/2020 | 09/30/2020 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 48.10K | 45.40K | 46.90K | 32.90K | 23.20K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 48.10K | 45.40K | 46.90K | 32.90K | 23.20K |
| Operating Income | -48.10K | -45.40K | -46.90K | -32.90K | -23.20K |
| Income Before Tax | -105.30K | -106.60K | -110.00K | -102.40K | -115.60K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.11 | -0.11 | -0.11 | -0.10 | -0.12 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -105.30K | -106.60K | -110.00K | -102.40K | -115.60K |
| EBIT | -48.10K | -45.40K | -46.90K | -32.90K | -23.20K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.01 | 0.00 | 0.00 | 0.00 | -0.29 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.18 |
| EPS Diluted | -0.01 | 0.00 | 0.00 | 0.00 | -0.29 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.18 |
| Average Basic Shares Outstanding | 128.53M | 180.20M | 221.34M | 216.26M | 159.54M |
| Average Diluted Shares Outstanding | 128.53M | 180.20M | 221.34M | 216.26M | 159.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |